胰岛素-核纳米颗粒用于受体向生物成像和糖尿病伤口愈合
Deepinder Sharda1, Diptiman Choudhury1,2
1School of Chemistry and Biochemistry, Thapar Institute of Engineering and Technology Patiala 147004 Punjab India diptiman@thapar.edu +91-8196949843.
RSC advances
|July 10, 2023
概括
这项研究开发了稳定,光的胰岛素-核心外纳米颗粒 (ICoNPs) 用于糖尿病伤口愈合和成像. 这些纳米颗粒显示出有针对性的生物成像和促进伤口恢复的潜力.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 医疗成像医学成像
背景情况:
- 糖尿病伤口带来了重大的临床挑战,需要先进的治疗和成像解决方案.
- 纳米配方包括蛋白质和金属离子可以调节炎症和微生物负载在伤口愈合.
- 目前的治疗方法缺乏有效的综合治疗和监测能力,用于糖尿病伤口管理.
研究的目的:
- 为了合成和表征高度光,生物相容的胰岛素-核纳米粒子 (ICoNPs).
- 评估ICoNPs在正常和糖尿病伤口愈合中针对生物成像和治疗应用的潜力.
- 确认蛋白质金属相互作用和受体结合,以加强伤口监测.
主要方法:
- 胰岛素-核心-外纳米颗粒 (ICoNPs) 的一个合成.
- 使用FTIR,拉曼光谱和物理化学性质分析进行了表征.
- 在体外评估生物相容性,伤口愈合效率 (HEKa细胞系) 和生物成像能力.
- 在分析以确定胰岛素上的结位.
主要成果:
- 成功合成了稳定,高光的ICoNPs,并提高了量子产量.
- 通过FTIR和拉曼光谱学证实了蛋白质金属相互作用.
- 证明了高负载效率 (89.48%) 和受控释放 (24小时内86.54%).
- 通过生物成像验证了ICoNP与胰岛素受体的结合,从而可以监测伤口的恢复.
结论:
- ICoNPs正在为糖尿病伤口愈合提供有前途的生物相容纳米疗法.
- 光特性允许实时监测伤口愈合过程.
- 这种综合方法为先进的伤口管理和有针对性的治疗提供了潜力.
相关概念视频
Insulin: The Receptor and Signaling Pathways
1.3K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
Insulin: Biosynthesis, Chemistry, and Preparation
435
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
435
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Insulin Formulations: Types and Delivery
232
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
232


